Skip to content
Open access

Replicative and Air Pollution-Induced Senescence: Telomere Dysfunction, Mitochondrial Stress, and Modulatory Effects of Astragaloside IV in Endothelial and Vascular Smooth Muscle Cells

Sep 2026 · Cardiovascular Toxicology · Vol 26 · 0 citations · 37 references
Medicine

TL;DR

It is demonstrated that vascular senescence is governed by cell type-specific telomere-mitochondria interactions that are differentially modulated by FD, and the selective protective effects of AS-IV in endothelial cells support the development of telomere-targeted therapeutic strategies to mitigate pollution-induced vascular aging.

Abstract

Telomere dysfunction and mitochondrial impairment are central drivers of vascular cell senescence and atherosclerosis, but their molecular interplay—especially under environmental stress—remains poorly defined. Fine particulate matter (PM) is an important contributor to vascular aging, but effective strategies to mitigate its detrimental effects are still lacking. This study investigated telomeric and mitochondrial alterations in human umbilical vein endothelial cells (HUVECs) and human coronary artery smooth muscle cells (hVSMCs) during replicative senescence (RS) and stress-induced premature senescence (SIPS), and evaluated the potential protective effects of Astragaloside IV (AS-IV), a natural compound with telomere and mitochondria-protective properties, against PM-induced vascular senescence. RS was induced by serial passaging and categorized as young (passages 6–7), intermediate (10–11), and old (17–20). SIPS was induced in early-passage cells by 48-h exposure to fine dust (FD), a PM10-like certified reference material representative of urban traffic emissions, at concentrations of 50 and 100 μg/mL. For the intervention experiments, cells were exposed to FD at 100 μg/mL for 48 h, followed by AS-IV (50 μM) for 24 h. Both HUVECs and hVSMCs showed hallmark features of RS, including SA-β-gal positivity, telomere shortening, activation of p16INK4a/p21Cip1, and mitochondrial dysfunction. FD-induced SIPS predominantly affected HUVECs, leading to premature senescence, telomere shortening, TERRA upregulation, and acute mitochondrial impairment, whereas hVSMCs showed relative resistance despite telomere shortening. AS-IV partially attenuated FD-induced telomeric and mitochondrial damage in HUVECs but had only limited effects in hVSMCs, underscoring the endothelial susceptibility to FD. These findings demonstrate that vascular senescence is governed by cell type-specific telomere-mitochondria interactions that are differentially modulated by FD. The selective protective effects of AS-IV in endothelial cells support the development of telomere-targeted therapeutic strategies to mitigate pollution-induced vascular aging.

Read PDF

Similar papers

Aug 2026

Dapagliflozin attenuates cellular senescence and mitochondrial dysfunction in diabetic kidney disease: potential involvement of AMPK/Sirt3 signaling.

Cellular senescence contributes to the pathology of diabetic kidney disease (DKD). Besides, mitochondrial dysfunction and cellular senescence are closely associated pathological processes that may influence one another during kidney injury progression. Dapagliflozin has demonstrated its renal protective benefits indepe...

Xin Tong, Bin Wang, Fen-Fei Gao et al. · 0 citations
Open access Sep 2026

Lactate Receptor Activation Alleviates Senescence and Preserves Homeostasis of Aged Arteries

These findings identify age-associated loss of GPR81 as a driver of vascular metabolic dysfunction and cellular senescence and establish pharmacological GPR81 activation as a promising therapeutic strategy for preserving vascular homeostasis and mitigating age-associated cardiovascular disease.

Yu-Lun Wu, Hamsa Vardini Senthil Kumar, Sai Harsha Bhamidipati et al. · 0 citations
Sep 2026

Aging-associated loss of CPEB4 impairs mitochondrial adaptation and promotes stress-induced senescence in alveolar type II cells.

Aging is associated with impaired lung repair and increased susceptibility to injury, yet the mechanisms underlying age-associated dysfunction of alveolar type II (AT2) cells remain poorly understood. Although cellular senescence is a hallmark of aging, emerging evidence suggests that aging is also characterized by pro...

Xin-Yi Li, Zhi-Fang Fu, Dan Sun et al. · 0 citations
Open access Aug 2026

Astragaloside IV attenuates hypoxia-reoxygenation-induced endothelial senescence and vascular inflammation by modulating the NOTCH1/VCAM-1 axis

The data suggest that AS-IV does not merely inhibit Notch1 but acts by modulating its signaling toward a protective equilibrium, thereby attenuating endothelial senescence and inflammation associated with the restoration of Notch1/VCAM-1 signaling balance.

De-Hui Huang, Rong-Jing Zhou, J. Ling · 0 citations
Sep 2026

Astragaloside IV Attenuates Cardiac Aging Through Restoring Mitochondrial Dynamics Homeostasis by Promoting SIRT3‐Mediated DRP1 Deacetylation

Cardiac aging is a major risk factor for cardiovascular diseases, with an imbalance in mitochondrial dynamics homeostasis being a pivotal aspect. Although Astragaloside IV (AS‐IV) has been shown to delay aging, its specific effects on cardiac aging and the link to mitochondrial dynamics remain unclear. This study aimed...

Xiao-Die Chen, Hui-Qun Huang, Yu-Tong Yang et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.